Centene to fund up to $100M in Washington U research


Centene Corp. and Washington University School of Medicine said Monday that they will partner to accelerate research into treatments for Alzheimer's disease, breast cancer, diabetes and obesity.

The Clayton-based managed health care provider will fund up to $100 million over 10 years in research at Washington U as part of the partnership, officials said. The funding will strengthen the medical school's Personalized Medicine Initiative, which targets development of customized disease treatment and…

Previous Alnylam trades partner Sanofi for Regeneron in $800M deal
Next Even with home prices among highest in U.S., Colorado property tax bills remain cheaper than most